-
-
-
-
-
-
-
AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis
-
-
-
-
-
-
-
Benitec Biopharma (BNTC) Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301
-
-
-
-
-
-
-
Eli Lilly (LLY) sleep apnea study data seen as a win, stock gains
-
-
-
-
-
-
-
Inspire Medical (INSP), ResMed (RMD) on Watch Following Report on Sleep Apnea
-
-
-
-
-
-
-
Teva Pharma (TEVA) and Teva (TEVA) Announce FDA Approval of SELARSDI
-
-
-
-
-
-
-
Inspira Technologies (IINN) Signs Term Sheet for Use of INSPIRA ART100 Device in Organ Transplant Procedures
-
-
-
-
-
-
-
Cullinan Therapeutics (CGEM) Announces Strategic Expansion into Autoimmune Diseases
-
66,826 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.